ClinConnect ClinConnect Logo
Search / Trial NCT06040762

A Home-Based Prehabilitation Exercise Intervention for Improving Physical Function in Patients With Bladder Cancer and Upper Tract Urothelial Cancer, Get Moving Trial

Launched by UNIVERSITY OF WASHINGTON · Sep 12, 2023

Trial Information

Current as of August 19, 2025

Recruiting

Keywords

ClinConnect Summary

The "Get Moving Trial" is studying a special exercise program designed to help patients with bladder cancer and upper tract urothelial cancer get stronger before their surgeries. This program, called prehabilitation, focuses on improving physical abilities like strength and balance through personalized exercise sessions that patients can do at home. Participants will use a mobile app called ExerciseRx to follow their exercise plans and set goals for daily activity. The aim is to see if being more active before surgery can help patients recover better and improve their overall surgical outcomes.

To join the trial, participants need to be at least 18 years old, speak English, and be scheduled for specific surgeries like radical cystectomy or nephroureterectomy. They should have enough time to complete at least four weeks of exercises before their surgery. However, people with certain health issues, cognitive impairments, or those who can't safely perform the exercises at home won't be eligible. If you join, you can expect to work closely with the research team to follow the exercise program and track your progress using the app.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 18 years of age or older
  • English-speaking
  • Planned treatment with radical cystectomy or radical nephroureterectomy/ureterectomy with or without preceding systemic therapy as indicated by the patient's surgeon with enough time to complete a minimum of 4 weeks of exercises before surgery if enrolled in the (P)REHAB arm
  • Willing and able to participate in trial activities
  • Exclusion Criteria:
  • Cognitive/mental impairment that will preclude ability to participate in routine exercise activities. Significant cognitive or memory impairment or baseline dementia that would preclude a patient's ability to follow instructions or reproduce exercises
  • Immobility, inability/unwillingness to perform personalized exercise program. Inability to perform exercises safely from seated or standing position at home or recent falls or high fall risk. Neurologic or orthopedic condition(s) that restricts participation in unsupervised home exercises, such as prior stroke with neurologic impairment, weight-bearing precautions, or unwillingness to participate in exercises
  • Participants who have nonmuscle-invasive urothelial cancer of the bladder/upper tract anticipating undergoing organ-preserving treatments, or radiographic evidence of metastatic disease involving other organs including brain metastases.
  • Patients with predominant histology other than urothelial carcinoma of the bladder or upper tracts (e.g. metastasis from another cancer) who would not otherwise be considered candidates for standard definitive or consolidative surgeries (radical cystectomy, ureterectomy, radical nephroureterectomy) with/without treatment with preoperative/neoadjuvant systemic therapy.
  • Uncontrolled or concurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements
  • Pregnant women are excluded from this study
  • Inability to understand or read English
  • Lack of access or lack of sufficient facility to use an Android or iOS smart device with the minimum criteria for using ExerciseRx
  • Not receiving surgery at UWMC
  • Participation in a clinical trial that does not permit enrollment in the Get Moving trial

About University Of Washington

The University of Washington (UW) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a robust network of interdisciplinary teams, UW fosters collaboration among top-tier researchers, clinicians, and healthcare professionals, aiming to translate scientific discoveries into impactful treatments and interventions. The university is dedicated to ethical research practices and participant safety, ensuring rigorous adherence to regulatory standards in all clinical trials. Through its state-of-the-art facilities and extensive expertise, UW strives to address pressing health challenges and improve patient outcomes on a local and global scale.

Locations

Seattle, Washington, United States

Patients applied

0 patients applied

Trial Officials

Sarah Psutka

Principal Investigator

Fred Hutch/University of Washington Cancer Consortium

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported